Raily Aesthetic Medicine International Holdings Limited Stock

Equities

2135

KYG7356A1215

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.14 HKD -7.89% Intraday chart for Raily Aesthetic Medicine International Holdings Limited -15.66% -70.83%

Financials

Sales 2022 165M 22.71M 178M Sales 2023 189M 26.14M 205M Capitalization 182M 25.16M 197M
Net income 2022 -15M -2.07M -16.21M Net income 2023 -32M -4.42M -34.57M EV / Sales 2022 1.51 x
Net cash position 2022 41.96M 5.79M 45.33M Net Debt 2023 11.99M 1.66M 12.96M EV / Sales 2023 1.03 x
P/E ratio 2022
-18.2 x
P/E ratio 2023
-5.61 x
Employees 335
Yield 2022 *
-
Yield 2023
-
Free-Float 55.54%
More Fundamentals * Assessed data
Dynamic Chart
Raily Aesthetic Medicine International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Raily Aesthetic Medicine Forecasts Wider Loss in 2023 MT
Raily Aesthetic Medicine International Holdings Limited Provides Earnings Guidance for the Year Ended 31 December 2023 CI
Raily Aesthetic Medicine International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Raily Aesthetic Medicine to Swing to H1 Loss MT
Raily Aesthetic Medicine International Holdings Limited Provides Earning Guidance for Six Months Ended 30 June 2023 CI
Raily Aesthetic Medicine International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Raily Aesthetic Expects Lower Net Loss MT
Raily Aesthetic Medicine to Trim 2022 Loss MT
Raily Aesthetic Medicine International Holdings Limited Provides Consolidated Unaudited Earnings Guidance for the Year Ended 31 December 2022 CI
Raily Aesthetic Medicine to Pay 20 Million Yuan Earnest Money to Aesthetic Medical Service Company MT
Raily Aesthetic Medicine International Holdings Limited Announces Resignation of Ms. Fan Qirui as A Non-Executive Director CI
Raily Aesthetic Medicine International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Raily Aesthetic Medicine International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Raily Aesthetic Medicine International Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2022 CI
More news
1 day-7.89%
1 week-15.66%
Current month-51.72%
1 month-48.15%
3 months-75.65%
6 months-72.00%
Current year-70.83%
More quotes
1 week
0.14
Extreme 0.14
0.17
1 month
0.14
Extreme 0.14
0.29
Current year
0.14
Extreme 0.14
0.63
1 year
0.14
Extreme 0.14
0.92
3 years
0.14
Extreme 0.14
5.25
5 years
0.14
Extreme 0.14
5.25
10 years
0.14
Extreme 0.14
5.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 69 19-05-29
Director of Finance/CFO 44 05-12-31
Corporate Secretary 45 20-11-26
Members of the board TitleAgeSince
Founder 51 08-07-31
Chief Executive Officer 69 19-05-29
Director/Board Member 48 20-12-03
More insiders
Date Price Change Volume
24-04-26 0.14 -7.89% 4,220,283
24-04-25 0.152 -5.59% 1,269,725
24-04-24 0.161 -1.83% 430,000
24-04-23 0.164 -2.38% 92,000
24-04-22 0.168 +1.20% 50,000

Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT

More quotes
Raily Aesthetic Medicine International Holdings Ltd is a China-based investment holding company mainly engaged in the provision of aesthetic medical services. The Company mainly operates through two segments. The Aesthetic Medical Services segment mainly includes inpatient services, including surgical services and outpatient services (including injection service, dermatology service and others). The Consulting Services segment principally includes management consulting services and aesthetic training courses. The Company mainly conducts business within the domestic market.
More about the company